News
FDA set to unveil new Covid vax guidelines today
While details of the guidance remain closely held, some clues are likely found in the FDA’s late Friday letter approving Novavax’s Covid vaccine. Who can get it: The license covers a limited population — adults 65 and older and people ages 12 to 64 with at least one underlying condition putting them at high risk for severe disease — compared with the two messenger RNA shots available for Covid recommended for all people 12 and older.
Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal ...
Send in your questions here. End of carousel The FDA was on track to grant full approval for the vaccine April 1, according to two people familiar with the matter who spoke on the condition of ...
The drug, Welireg, became the first FDA-approved oral treatment for the two tumors — pheochromocytoma and paraganglioma. The ...
The FDA will require vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals.
No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.
Live Science on MSN1d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback